Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0102 Transporter Info | ||||
Gene Name | SLC16A11 | ||||
Transporter Name | Monocarboxylate transporter 11 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Colon cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg18353345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 1.84E-03; Z-score: -1.25E+00 | ||
Methylation in Case |
9.45E-02 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg04913974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 2.37E-04; Z-score: -2.50E+00 | ||
Methylation in Case |
4.50E-01 (Median) | Methylation in Control | 5.56E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
1stExon (cg26923754) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.43E-03; Z-score: -9.57E-01 | ||
Methylation in Case |
5.05E-01 (Median) | Methylation in Control | 5.37E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg04569615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.13E-03; Z-score: 9.77E-01 | ||
Methylation in Case |
6.93E-01 (Median) | Methylation in Control | 6.11E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg19130824) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.40E-03; Z-score: 7.47E-01 | ||
Methylation in Case |
7.77E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg14808360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.66E-03; Z-score: 8.33E-01 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 8.87E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in colon adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 1.99E-03; Z-score: -1.63E+00 | ||
Methylation in Case |
5.73E-01 (Median) | Methylation in Control | 6.48E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg21090344) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.03E+00 | Statistic Test | p-value: 8.38E-09; Z-score: -8.53E+00 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 5.12E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg14950751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 2.58E-05; Z-score: -3.68E+00 | ||
Methylation in Case |
2.29E-01 (Median) | Methylation in Control | 3.37E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg16374411) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 7.47E-04; Z-score: -3.92E+00 | ||
Methylation in Case |
1.83E-01 (Median) | Methylation in Control | 2.70E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.48E+00 | Statistic Test | p-value: 2.91E-03; Z-score: -2.72E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg07011163) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 2.93E-02; Z-score: -1.28E+00 | ||
Methylation in Case |
1.09E-01 (Median) | Methylation in Control | 1.33E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg03892045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.75E+00 | Statistic Test | p-value: 4.01E-02; Z-score: -1.66E+00 | ||
Methylation in Case |
5.71E-02 (Median) | Methylation in Control | 1.00E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg05031424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 1.13E-05; Z-score: -3.21E+00 | ||
Methylation in Case |
5.02E-01 (Median) | Methylation in Control | 6.50E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg03096732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 2.31E-05; Z-score: -4.23E+00 | ||
Methylation in Case |
1.19E-01 (Median) | Methylation in Control | 1.71E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC16A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg18736141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.53E+00 | Statistic Test | p-value: 5.70E-03; Z-score: -2.23E+00 | ||
Methylation in Case |
1.18E-01 (Median) | Methylation in Control | 1.81E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg21090344) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.87E-03; Z-score: -5.87E-01 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 6.29E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg16374411) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 1.33E-02; Z-score: 9.06E-01 | ||
Methylation in Case |
2.96E-01 (Median) | Methylation in Control | 2.68E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg07011163) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 5.08E-06; Z-score: 2.04E+00 | ||
Methylation in Case |
1.42E-01 (Median) | Methylation in Control | 9.97E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.45E+00 | Statistic Test | p-value: 1.16E-05; Z-score: 1.99E+00 | ||
Methylation in Case |
1.68E-01 (Median) | Methylation in Control | 1.16E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg03892045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.44E+00 | Statistic Test | p-value: 8.00E-05; Z-score: 1.21E+00 | ||
Methylation in Case |
8.67E-02 (Median) | Methylation in Control | 6.01E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg08352268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 1.77E-03; Z-score: 8.79E-01 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 9.58E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg03712541) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 3.75E-03; Z-score: 5.92E-01 | ||
Methylation in Case |
5.01E-02 (Median) | Methylation in Control | 3.54E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg18530716) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 7.36E-03; Z-score: 5.81E-01 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 8.49E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg02489908) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.76E-06; Z-score: 1.97E+00 | ||
Methylation in Case |
3.54E-01 (Median) | Methylation in Control | 2.92E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg18736141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.05E-03; Z-score: 6.15E-01 | ||
Methylation in Case |
2.04E-01 (Median) | Methylation in Control | 1.83E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg01019875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.23E-02; Z-score: 1.61E-01 | ||
Methylation in Case |
1.80E-01 (Median) | Methylation in Control | 1.72E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg03096732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 3.83E-02; Z-score: -1.36E+00 | ||
Methylation in Case |
1.40E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC16A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg19639560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.93E-02; Z-score: 2.44E-01 | ||
Methylation in Case |
5.55E-01 (Median) | Methylation in Control | 5.31E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg16374411) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.42E-03; Z-score: 7.24E-01 | ||
Methylation in Case |
3.57E-01 (Median) | Methylation in Control | 3.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg14950751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 2.77E-03; Z-score: 6.82E-01 | ||
Methylation in Case |
2.58E-01 (Median) | Methylation in Control | 2.20E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg07011163) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.28E-04; Z-score: 9.62E-01 | ||
Methylation in Case |
1.93E-01 (Median) | Methylation in Control | 1.67E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 4.23E-04; Z-score: 1.01E+00 | ||
Methylation in Case |
2.23E-01 (Median) | Methylation in Control | 1.94E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg03892045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 6.17E-03; Z-score: 8.41E-01 | ||
Methylation in Case |
5.59E-02 (Median) | Methylation in Control | 4.55E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg18530716) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.20E-02; Z-score: 5.93E-01 | ||
Methylation in Case |
2.05E-01 (Median) | Methylation in Control | 1.77E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg03712541) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 1.71E-02; Z-score: 5.49E-01 | ||
Methylation in Case |
3.15E-02 (Median) | Methylation in Control | 2.35E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC16A11 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg05031424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 5.53E-10; Z-score: -2.33E+00 | ||
Methylation in Case |
8.07E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg21090344) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 5.41E-04; Z-score: -7.66E-01 | ||
Methylation in Case |
4.15E-01 (Median) | Methylation in Control | 4.97E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg14950751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 2.51E-02; Z-score: -7.25E-01 | ||
Methylation in Case |
2.89E-01 (Median) | Methylation in Control | 3.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg13167631) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.18E+00 | Statistic Test | p-value: 2.00E-15; Z-score: -2.20E+00 | ||
Methylation in Case |
2.44E-01 (Median) | Methylation in Control | 5.33E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg03816707) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.38E+00 | Statistic Test | p-value: 7.29E-24; Z-score: 4.51E+00 | ||
Methylation in Case |
5.10E-01 (Median) | Methylation in Control | 2.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg21227867) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.52E+00 | Statistic Test | p-value: 3.21E-19; Z-score: -4.47E+00 | ||
Methylation in Case |
4.83E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg18736141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.51E+00 | Statistic Test | p-value: 1.91E-07; Z-score: -1.75E+00 | ||
Methylation in Case |
1.74E-01 (Median) | Methylation in Control | 2.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg02489908) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.58E+00 | Statistic Test | p-value: 2.97E-07; Z-score: -1.94E+00 | ||
Methylation in Case |
1.98E-01 (Median) | Methylation in Control | 3.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg19639560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 3.12E-07; Z-score: -1.18E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 5.39E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC16A11 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg05031424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 7.35E-05; Z-score: -8.11E-01 | ||
Methylation in Case |
5.41E-01 (Median) | Methylation in Control | 6.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg16374411) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 1.33E-03; Z-score: -1.85E+00 | ||
Methylation in Case |
3.63E-01 (Median) | Methylation in Control | 4.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg14950751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 2.95E-03; Z-score: -2.66E+00 | ||
Methylation in Case |
3.45E-01 (Median) | Methylation in Control | 4.48E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 9.35E-03; Z-score: -1.55E+00 | ||
Methylation in Case |
2.50E-01 (Median) | Methylation in Control | 3.32E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg01532168) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.53E+00 | Statistic Test | p-value: 1.02E-12; Z-score: 2.73E+00 | ||
Methylation in Case |
4.49E-01 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg17445913) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 2.90E-09; Z-score: 4.49E-01 | ||
Methylation in Case |
1.82E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg27435138) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.09E-03; Z-score: 7.39E-01 | ||
Methylation in Case |
8.01E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg11699666) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.36E-02; Z-score: 6.02E-01 | ||
Methylation in Case |
5.87E-02 (Median) | Methylation in Control | 5.14E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg24751648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 1.55E-04; Z-score: -1.01E+00 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.54E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg02780017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 6.09E-04; Z-score: -9.65E-01 | ||
Methylation in Case |
5.44E-01 (Median) | Methylation in Control | 6.81E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg26426186) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.47E-07; Z-score: -6.73E-01 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg09945896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 6.80E-05; Z-score: -7.78E-01 | ||
Methylation in Case |
7.63E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg18104539) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.69E-04; Z-score: -6.98E-01 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg04794858) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 1.39E-03; Z-score: 1.16E+00 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg08799967) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.68E-02; Z-score: 7.13E-01 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg05369268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.76E-02; Z-score: 6.29E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 8.71E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC16A11 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg05868813) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 3.02E-10; Z-score: -1.95E+00 | ||
Methylation in Case |
5.68E-01 (Median) | Methylation in Control | 7.35E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg14950751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.02E-01 | Statistic Test | p-value: 1.30E-03; Z-score: -4.59E-01 | ||
Methylation in Case |
-1.94E+00 (Median) | Methylation in Control | -1.75E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in panic disorder | [ 8 ] | |||
Location |
TSS200 (cg03892045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.68E-01 | Statistic Test | p-value: 2.69E-02; Z-score: -2.43E-01 | ||
Methylation in Case |
-4.85E+00 (Median) | Methylation in Control | -4.69E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in panic disorder | [ 8 ] | |||
Location |
Body (cg01019875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.93E-01 | Statistic Test | p-value: 2.77E-02; Z-score: -5.76E-01 | ||
Methylation in Case |
-4.96E+00 (Median) | Methylation in Control | -4.42E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Celiac disease |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in celiac disease | [ 9 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.02E+00 | Statistic Test | p-value: 4.73E-02; Z-score: 1.27E+00 | ||
Methylation in Case |
8.13E-02 (Median) | Methylation in Control | 2.69E-02 (Median) | ||
Studied Phenotype |
Celiac disease [ ICD-11: DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg07011163) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 7.39E-03; Z-score: 5.81E-01 | ||
Methylation in Case |
2.26E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg13181928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.63E+00 | Statistic Test | p-value: 9.31E-03; Z-score: 2.32E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 2.56E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg03712541) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.20E-02; Z-score: -1.43E-01 | ||
Methylation in Case |
5.28E-02 (Median) | Methylation in Control | 5.90E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg08352268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.32E-02; Z-score: 1.43E-01 | ||
Methylation in Case |
9.97E-02 (Median) | Methylation in Control | 9.36E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
Body (cg02489908) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.25E-03; Z-score: 1.46E+00 | ||
Methylation in Case |
3.23E-01 (Median) | Methylation in Control | 2.79E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
Body (cg18736141) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.28E-02; Z-score: 4.71E-01 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 1.16E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC16A11 in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
Body (cg05031424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.56E-02; Z-score: -6.76E-01 | ||
Methylation in Case |
7.02E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC16A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg05031424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.43E-05; Z-score: -9.34E-01 | ||
Methylation in Case |
8.41E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC16A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg02489908) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 4.41E-05; Z-score: 1.21E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 2.82E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC16A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg03096732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 3.82E-03; Z-score: -8.50E-01 | ||
Methylation in Case |
1.64E-01 (Median) | Methylation in Control | 2.03E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC16A11 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.33E-09; Fold-change: 0.407605361; Z-score: 5.731705893 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.